Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator.
Luigi A M J G van RielAuke JagerDennie MeijerArnoud W PostemaRuth S SmitAndré N VisTheo M de ReijkeHarrie P BeerlageJorg R OddensPublished in: Therapeutic advances in urology (2022)
The developed RC (Prostate Biopsy Cohort Amsterdam ('PROBA' RC), integrated predictors for csPCa at prostate biopsy in negative-MRI men and outperformed other widely used RCs. These findings require external validation before introduction in daily practice.